Escape from immunotherapy: possible mechanisms that influence tumor regression/progression Murrium AhmadRobert C. ReesSelman A. Ali Review 10 June 2004 Pages: 844 - 854
The paradox of T cell–mediated antitumor immunity in spite of poor clinical outcome in human melanoma Andrea AnichiniClaudia VegettiRoberta Mortarini Review 03 June 2004 Pages: 855 - 864
Down-regulation of ζ-chain expression in T cells: a biomarker of prognosis in cancer? Theresa L. Whiteside Review 29 April 2004 Pages: 865 - 878
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes Constantin N. BaxevanisMichael Papamichail Review 26 May 2004 Pages: 893 - 903
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape Ignacio AlgarraAngel García-LoraFederico Garrido Review 07 April 2004 Pages: 904 - 910
Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword? Raquel TarazonaJavier G. CasadoRafael Solana Review 04 May 2004 Pages: 911 - 924
Replicative senescence of CD8 T cells: potential effects on cancer immune surveillance and immunotherapy Rita B. Effros Review 06 April 2004 Pages: 925 - 933